Indication
Squamous cell carcinoma of vulva
Squamous cell carcinoma of the vulva is an invasive epithelial malignancy arising from the stratified squamous epithelium of the female external genitalia, predominantly affecting the labia majora and labia minora. Read more about Squamous cell carcinoma of vulva
12 drugs 12 manufacturers
Drugs that treat it
Common Squamous cell carcinoma of vulva therapies.
BLEOMYCIN (bleomycin sulfate)
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSquamous cell carcinoma of the vulva is an invasive epithelial malignancy arising from the stratified squamous epithelium of the female external genitalia, predominantly affecting the labia majora and labia minora.
It represents the vast majority of vulvar cancers and typically affects postmenopausal individuals, though it also occurs in younger populations.
Pathophysiologically, the disease develops through two main pathways: a human papillomavirus (HPV)–dependent route driven by persistent high-risk HPV infection, or an HPV-independent route commonly associated with chronic inflammatory dermatoses, such as lichen sclerosus, and frequent TP53 mutations.
Clinically, it typically presents with persistent vulvar pruritus, pain, ulceration, or a visible exophytic or nodular mass that may bleed or cause localized discharge.
- nih.gov
Squamous cell carcinoma of the vulva is an invasive epithelial malignancy arising from the stratified squamous epithelium of the female external genitalia, predominantly affecting the labia majora and labia minora It represents the vast majority of vulvar cancers and typically affects postmenopausal individuals, though it also occurs in younger populations Clinically, it typically presents with persistent vulvar pruritus, pain, ulceration, or a visible exophytic or nodular mass that may bleed or...
- nih.gov
It represents the vast majority of vulvar cancers and typically affects postmenopausal individuals, though it also occurs in younger populations Pathophysiologically, the disease develops through two main pathways: a human papillomavirus (HPV)–dependent route driven by persistent high-risk HPV infection, or an HPV-independent route commonly associated with chronic inflammatory dermatoses, such as lichen sclerosus, and frequent TP53 mutations
- nih.gov
It represents the vast majority of vulvar cancers and typically affects postmenopausal individuals, though it also occurs in younger populations
- nih.gov
Pathophysiologically, the disease develops through two main pathways: a human papillomavirus (HPV)–dependent route driven by persistent high-risk HPV infection, or an HPV-independent route commonly associated with chronic inflammatory dermatoses, such as lichen sclerosus, and frequent TP53 mutations
- nih.gov
Clinically, it typically presents with persistent vulvar pruritus, pain, ulceration, or a visible exophytic or nodular mass that may bleed or cause localized discharge
Personalize your experience
Follow Squamous cell carcinoma of vulva and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.